Pharmaceutical Technology-08-01-2001

Effective partnerships between research and manufacturing operations can streamline the process of bringing a product to market.

The consolidation of the contract manufacturing industry has spread to the parenteral fill-finish segment, with two deals announced just before this year's Fourth of July holiday.

A CRO and a client company must plan strategically together to minimize and prevent possible project roadblocks.

Careful planning and decision-making can circumvent possible delays in technology transfers.

The demand for CGMP production of biopharmaceuticals is at an all-time high.

By following a step&#173by&#173step process for preparing a request for quotation, one can easily prepare a bid for outsourcing a project.

Successfully taking a new chemical entity from proof-of-concept to commercialization requires the biopharmaceutical company to carefully evaluate a contract services provider's formulation department and ability to become a fully integrated supplier.

The vulnerability of both the sponsors and the contractors has increased tremendously.

To maximize the value of outsourcing, pharmaceutical and biotech companies are realizing the importance of close partnerships with their contract service providers.